首页> 美国卫生研究院文献>The Neuroradiology Journal >Accuracy of percentage of signal intensity recovery and relative cerebral blood volume derived from dynamic susceptibility-weighted contrast-enhanced MRI in the preoperative diagnosis of cerebral tumours
【2h】

Accuracy of percentage of signal intensity recovery and relative cerebral blood volume derived from dynamic susceptibility-weighted contrast-enhanced MRI in the preoperative diagnosis of cerebral tumours

机译:动态敏感性加权对比增强MRI得出的信号强度恢复百分比和相对脑血容量在脑肿瘤术前诊断中的准确性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Conventional magnetic resonance imaging (MRI) is the technique of choice for diagnosis of cerebral tumours, and has become an increasingly powerful tool for their evaluation; however, the diagnosis of common contrast-enhancing lesions can be challenging, as it is sometimes impossible to differentiate them using conventional imaging. Histopathological analysis of biopsy specimens is the gold standard for diagnosis; however, there are significant risks associated with the invasive procedure and definitive diagnosis is not always achieved. Early accurate diagnosis is important, as management differs accordingly. Advanced MRI techniques have increasing utility for aiding diagnosis in a variety of clinical scenarios. Dynamic susceptibility-weighted contrast-enhanced (DSC) MRI is a perfusion imaging technique and a potentially important tool for the characterisation of cerebral tumours. The percentage of signal intensity recovery (PSR) and relative cerebral blood volume (rCBV) derived from DSC MRI provide information about tumour capillary permeability and neoangiogenesis, which can be used to characterise tumour type and grade, and distinguish tumour recurrence from treatment-related effects. Therefore, PSR and rCBV potentially represent a non-invasive means of diagnosis; however, the clinical utility of these parameters has yet to be established. We present a review of the literature to date.
机译:传统的磁共振成像(MRI)是诊断脑肿瘤的首选技术,并且已成为评估它们的越来越强大的工具。但是,常见的对比增强病变的诊断可能具有挑战性,因为有时无法使用常规成像来区分它们。活检标本的组织病理学分析是诊断的金标准。但是,与侵入性手术相关的风险很大,而且不一定总是能做出明确的诊断。早期准确诊断很重要,因为管理方法会有所不同。先进的MRI技术在各种临床情况下辅助诊断的实用性不断提高。动态磁化率加权对比增强(DSC)MRI是一种灌注成像技术,并且是表征脑肿瘤的潜在重要工具。来自DSC MRI的信号强度恢复(PSR)和相对脑血容量(rCBV)的百分比提供有关肿瘤毛细血管通透性和新血管生成的信息,可用于表征肿瘤类型和等级,并从治疗相关效应中区分肿瘤复发。因此,PSR和rCBV可能代表一种非侵入性的诊断手段。然而,这些参数的临床应用尚待确定。我们提出了迄今为止的文献综述。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号